Description
According to research, Retatrutide, a GIP–GLP-1–GCG receptor triple agonist, reduces feelings of hunger, lowers insulin levels, and increases insulin sensitivity, which can cause significant weight loss, improve glucose tolerance, decrease fat/adipose tissue, reduce cardiovascular risk, may provide neuroprotective effects and may be a new tool in treating addiction.



Caliope Bartok –
On my 3rd Vile and Ive Lost 22 Pounds! Thanks Ascension!